Tranq’in
…since xylazine isn’t itself an opioid, the antagonist naloxone won’t reverse its effects. Even with prompt treatment, the user can still experience respiratory arrest.
Read MoreSelect Page
Posted by C. Scott McMillin | Apr 10, 2023 | Addictive Substances | 0 |
…since xylazine isn’t itself an opioid, the antagonist naloxone won’t reverse its effects. Even with prompt treatment, the user can still experience respiratory arrest.
Read MorePosted by C. Scott McMillin | Apr 6, 2023 | Public Policy | 0 |
…simply by lowering the standard BAC from .08 to .05, we could save an estimated 1500 lost lives every year. Not to mention approximately $121 billion in associated medical, legal, property, and productivity costs.
Read MorePosted by C. Scott McMillin | Apr 3, 2023 | Addictive Substances | 0 |
Anybody concerned that some GHB-based prescribed meds will be diverted for illicit use?
Read MorePosted by C. Scott McMillin | Mar 30, 2023 | Addictive Substances | 0 |
Colleges, in my experience, have a weirdly ambivalent attitude towards this kind of behavior from their students.
Read MorePosted by C. Scott McMillin | Mar 27, 2023 | Thinking About Addiction | 0 |
…there are now some 300,000 Americans on methadone maintenance, and I’m assuming many of them will not want to transition to buprenorphine.
Read More